Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 51 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 90 | 3,162−8.5%/yr | −8.5%/yr | 3.10.9× | 17% | 3,120 in 2030−0.2%/yr |
| Lumbar fusion | 81 | 3,107−4.5%/yr | −4.5%/yr | 3.00.9× | 0% | 3,140 in 2030+0.2%/yr |
| Cervical fusion & disc arthroplasty | 26 | 1,686−6.3%/yr | −6.3%/yr | 1.61.0× | 6% | 1,550 in 2030−1.4%/yr |
| Kyphoplasty & vertebroplasty | 16 | 1,376−9.2%/yr | −9.2%/yr | 1.40.8× | 27% | 1,380 in 20300%/yr |
| SI joint fusion | 3 | 167+8.3%/yr | +8.3%/yr | 0.10.4× | 13% | 340 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 411 | 84,720−6.3%/yr | −6.3%/yr | 81.10.7× | 34% | 87,500 in 2030+0.5%/yr |
| Skin substitutes & wound grafts | 35 | 7,475+4.4%/yr | +4.4%/yr | 4.40.4× | 66% | 10,800 in 2030+6.4%/yr |
| Bone graft & orthobiologics | 14 | 525−14%/yr | −14%/yr | 0.50.7× | 2% | 520 in 2030−0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 172 | 11,392−0.4%/yr | −0.4%/yr | 10.90.8× | 82% | 12,200 in 2030+1.2%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 21 | 1,154+13%/yr | +13%/yr | 1.10.8× | 42% | 1,560 in 2030+5.2%/yr |
| Spinal cord & DRG stimulation | 27 | 1,005−2%/yr | −2%/yr | 0.91.0× | 45% | 950 in 2030−0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 55 | 5,158−18%/yr | −18%/yr | 5.41.0× | 66% | 4,610 in 2030−1.9%/yr |
| Peripheral arterial intervention | 34 | 4,853−8.1%/yr | −8.1%/yr | 4.60.7× | 39% | 4,620 in 2030−0.8%/yr |
| Superficial venous ablation | 57 | 4,216−3.9%/yr | −3.9%/yr | 4.00.6× | 97% | 3,890 in 2030−1.3%/yr |
| Thrombectomy, IVC filters & venous stents | 4 | 1,069−0.8%/yr | −0.8%/yr | 1.10.6× | 0% | 1,460 in 2030+5.4%/yr |
| Carotid revascularization | 17 | 916−10%/yr | −10%/yr | 0.90.7× | 0% | 940 in 2030+0.4%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 449−8.3%/yr | −8.3%/yr | 0.50.9× | 0% | 420 in 2030−1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 69 | 5,606−5%/yr | −5%/yr | 6.01.0× | 6% | 6,060 in 2030+1.3%/yr |
| Cholecystectomy & appendectomy | 77 | 4,307−7.3%/yr | −7.3%/yr | 4.51.0× | 2% | 4,130 in 2030−0.7%/yr |
| Colorectal resection | 8 | 1,589−6.5%/yr | −6.5%/yr | 1.61.0× | 0% | 1,360 in 2030−2.6%/yr |
| Antireflux & hiatal hernia surgery | 13 | 605−3.6%/yr | −3.6%/yr | 0.60.8× | 0% | 850 in 2030+5.9%/yr |
| Breast reconstruction | 0 | 327−13%/yr | −13%/yr | 0.30.7× | 0% | 330 in 2030−0.1%/yr |
| Bariatric surgery | 0 | 167−18%/yr | −18%/yr | 0.20.9× | 0% | 80 in 2030−11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 103 | 4,811−5%/yr | −5%/yr | 4.91.0× | 5% | 5,000 in 2030+0.6%/yr |
| BPH procedures | 53 | 4,163−9.2%/yr | −9.2%/yr | 4.20.8× | 15% | 3,750 in 2030−1.7%/yr |
| Hysterectomy, hysteroscopy & ablation | 30 | 2,572−2.1%/yr | −2.1%/yr | 2.91.1× | 10% | 2,740 in 2030+1.1%/yr |
| Incontinence, prolapse & sacral neuromodulation | 32 | 2,349−2.5%/yr | −2.5%/yr | 2.40.9× | 5% | 2,230 in 2030−0.8%/yr |
| Prostatectomy & nephrectomy | 14 | 1,126−2.7%/yr | −2.7%/yr | 1.31.0× | 0% | 1,310 in 2030+2.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 39 | 3,683−8.4%/yr | −8.4%/yr | 3.80.7× | 87% | 4,040 in 2030+1.6%/yr |
| Cochlear implants | 5 | 192+9.9%/yr | +9.9%/yr | 0.21.2× | 21% | 300 in 2030+7.5%/yr |
| Ear tubes & middle ear surgery | 0 | 179−7.8%/yr | −7.8%/yr | 0.20.5× | 49% | 500 in 2030+19%/yr |
| Sleep apnea & airway implants | 6 | 178+96%/yr | +96%/yr | 0.20.7× | 0% | 270 in 2030+7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 133 | 8,308−3%/yr | −3%/yr | 9.01.3× | 45% | 8,490 in 2030+0.4%/yr |
| Tumor & fibroid embolization | 11 | 795+10%/yr | +10%/yr | 0.81.5× | 63% | 1,900 in 2030+16%/yr |
| Tumor ablation | 3 | 334−1.9%/yr | −1.9%/yr | 0.31.1× | 0% | 320 in 2030−0.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 229 | 28,955+18%/yr | +18%/yr | 28.61.0× | 87% | 48,600 in 2030+9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 100 | 4,907−3.4%/yr | −3.4%/yr | 5.20.9× | 0% | 5,080 in 2030+0.6%/yr |
| EP ablation | 76 | 3,911+8.1%/yr | +8.1%/yr | 3.30.9× | 0% | 6,900 in 2030+9.9%/yr |
| LAA occlusion & loop recorders | 76 | 2,760+8.6%/yr | +8.6%/yr | 2.40.6× | 7% | 4,660 in 2030+9.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 124 | 5,638−9.6%/yr | −9.6%/yr | 4.60.7× | 0% | 6,040 in 2030+1.2%/yr |
| Structural heart (TAVR, TEER) | 75 | 1,460−1.4%/yr | −1.4%/yr | 1.20.8× | 0% | 2,070 in 2030+6%/yr |
| Mechanical circulatory support | 1 | 534−5.9%/yr | −5.9%/yr | 0.51.0× | 0% | 550 in 2030+0.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 15 | 435−2.3%/yr | −2.3%/yr | 0.51.1× | 0% | 420 in 2030−0.8%/yr |
| Aneurysm & intracranial embolization | 13 | 383+6.3%/yr | +6.3%/yr | 0.40.9× | 0% | 640 in 2030+8.8%/yr |
| DBS & VNS | 8 | 293−8.9%/yr | −8.9%/yr | 0.30.9× | 0% | 440 in 2030+7.1%/yr |
| CSF shunts | 2 | 190−7.9%/yr | −7.9%/yr | 0.21.0× | 0% | 170 in 2030−1.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 248 | 74,301+0.5%/yr | +0.5%/yr | 73.41.3× | 66% | 87,500 in 2030+2.8%/yr |
| Vitreoretinal surgery | 33 | 2,261−4%/yr | −4%/yr | 2.30.9× | 36% | 2,170 in 2030−0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 544 | 112,191−5.4%/yr | −5.4%/yr | 117.81.0× | 61% | 111,000 in 2030−0.2%/yr |
| ERCP & endoscopic ultrasound | 52 | 3,646−1.8%/yr | −1.8%/yr | 3.81.2× | 5% | 3,960 in 2030+1.4%/yr |
| Bronchoscopy & lung nodule | 56 | 3,414+0.2%/yr | +0.2%/yr | 3.51.0× | 0% | 4,080 in 2030+3%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.